Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06423703 · ClinicalTrials.gov registry record · Phase 3

A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy

A Phase 3 study of Acute Pain, sponsored by Tris Pharma.

Completed
Registry status
Phase 3
Development phase
240
Enrollment target
10
Study locations

NCT06423703 is a Phase 3 study of Acute Pain that has completed, run by Tris Pharma. The registered enrollment target is 240 participants, roughly in line with the 263-participant average among 50 other Acute Pain trials with a reported enrollment target. The trial reports 10 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06423703, a Phase 3 study of Acute Pain, has completed, sponsored by Tris Pharma.

COMPLETED
Registry status
Phase 3
Development phase
240 participants
Enrollment target
10
Study locations

Study Summary

The purpose of this study is to evaluate the efficacy and safety of Cebranopadol for acute pain after a bunionectomy.

Conditions Studied

Acute Pain

Interventions

  • DRUG Placebo
  • DRUG Cebranopadol
  • DRUG Oxycodone IR
  • DRUG Placebo Only

Study Locations (10)

Texas

  • Alleviate 2 001113 - Houston
  • ALLEVIATE 2 Site 001104 - McAllen
  • ALLEVIATE 2 Site 001111 - San Antonio

Alabama

  • ALLEVIATE 2 Site 001108 - Sheffield

Arkansas

  • ALLEVIATE 2 Site 001106 - Little Rock

Florida

  • ALLEVIATE 2 Site 001103 - Tampa

Georgia

  • ALLEVIATE 2 Site 001102 - Atlanta

Kansas

  • ALLEVIATE 2 Site 001107 - Overland Park

Maryland

  • ALLEVIATE 2 Site 001105 - Pasadena

Utah

  • ALLEVIATE 2 Site 001101 - Salt Lake City

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2024-07-18
Est. Completion 2025-01-31
Phase Phase 3

Sponsor

Tris Pharma

14 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06423703

The ClinicalTrials.gov registry entry for NCT06423703 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 263-participant average among 50 other Acute Pain trials with a reported enrollment target. The listed sponsor is Tris Pharma, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Pain appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.

NCT06423703 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Texas, Alabama, Arkansas.

Frequently Asked Questions

What is clinical trial NCT06423703 about?

NCT06423703 is a clinical study titled "A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy". The purpose of this study is to evaluate the efficacy and safety of Cebranopadol for acute pain after a bunionectomy.

What is the current status of trial NCT06423703?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 240 participants. The study started on 2024-07-18. Estimated completion is 2025-01-31.

What conditions does trial NCT06423703 study?

This clinical trial studies the following conditions: Acute Pain.

What interventions are being tested in trial NCT06423703?

The interventions under investigation include: Placebo (DRUG), Cebranopadol (DRUG), Oxycodone IR (DRUG), Placebo Only (DRUG).

Who is sponsoring clinical trial NCT06423703?

This trial is sponsored by Tris Pharma, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06423703 being conducted?

This trial has 10 study locations across Alabama, Arkansas, Florida, Georgia, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acute Pain

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.